Not available
Quote | Celldex Therapeutics Inc. (NASDAQ:CLDX)
Last: | $36.36 |
---|---|
Change Percent: | -1.21% |
Open: | $35.93 |
Close: | $36.36 |
High: | $36.65 |
Low: | $35.38 |
Volume: | 371,880 |
Last Trade Date Time: | 07/08/2024 03:00:00 am |
News | Celldex Therapeutics Inc. (NASDAQ:CLDX)
2024-06-18 13:18:09 ET More on Celldex Celldex Therapeutics: Rising High, With Room For Further Growth Celldex initiated to outperform at Wolfe on barzolvolimab for skin disease Seeking Alpha’s Quant Rating on Celldex Historical earnings data for Celld...
2024-06-17 18:00:08 ET Alex Thompson from Stifel Nicolaus issued a price target of $58.00 for CLDX on 2024-06-17 16:15:00. The adjusted price target was set to $58.00. At the time of the announcement, CLDX was trading at $34.91. The overall price target consensus is at $...
Message Board Posts | Celldex Therapeutics Inc. (NASDAQ:CLDX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CLDX News Article - Celldex Therapeutics to Present at H.C. Wainwright Autoimmune & In | whytestocks | investorshangout | 03/29/2023 6:50:56 PM |
COULD BE. | fwb | investorshub | 03/01/2023 8:40:33 PM |
Could be a buyout coming | harry crumb | investorshub | 03/01/2023 4:23:23 PM |
Another positive for cldx $$$$ | harry crumb | investorshub | 02/27/2023 12:24:53 PM |
This stock use to be called Avant Immunotherapeutics | fwb | investorshub | 02/07/2023 9:02:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Celldex Therapeutics Inc. Company Name:
CLDX Stock Symbol:
NASDAQ Market:
Celldex Therapeutics Inc. Website:
2024-06-17 18:00:08 ET Alex Thompson from Stifel Nicolaus issued a price target of $58.00 for CLDX on 2024-06-17 16:15:00. The adjusted price target was set to $58.00. At the time of the announcement, CLDX was trading at $34.91. The overall price target consensus is at $...
2024-06-10 19:15:02 ET Wolfe Research analyst issues OUTPERFORM recommendation for CLDX on June 10, 2024 06:14PM ET. CLDX was trading at $34.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy, 1 -...
2024-06-10 15:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...